Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Anticoagulants remain focus of research at Warner-Lambert

Oct. 29, 1999

Warner-Lambert discloses another series of anticoagulants

Oct. 28, 1999

Warner-Lambert patents new anticoagulants with quinolinone structure

Oct. 27, 1999

First approval obtained for bivalirudin

Oct. 26, 1999

LMW heparin to be marketed in U.K. and Ireland by ICN

Oct. 26, 1999

New anticoagulants in the pipeline at DuPont

Oct. 25, 1999

Essex Pharma launches clot buster in Germany

Oct. 20, 1999

Merck's new fibrinogen receptor antagonists disclosed in recent patent

Oct. 14, 1999

BCH-2763 shows antithrombotic activity in canine model of DVT

Oct. 8, 1999

Pharming awarded grants for human lactoferrin research; announces collaboration

Oct. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...